相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients
Kohei Matsushita et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Soluble CXCL16 and long-term outcome in acute ischemic stroke
T. Ueland et al.
ATHEROSCLEROSIS (2012)
Discrimination of agonist and antagonist forms of CXCL10 in biological samples
A. Casrouge et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response
Mieke Gouwy et al.
IMMUNOLOGY LETTERS (2012)
Overview of the mechanisms regulating chemokine activity and availability
Anneleen Mortier et al.
IMMUNOLOGY LETTERS (2012)
Human Cytomegalovirus Clinical Strain-Specific microRNA miR-UL148D Targets the Human Chemokine RANTES during Infection
Youngkyun Kim et al.
PLOS PATHOGENS (2012)
MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1+/Lin- progenitor cells in ischaemia
Coen van Solingen et al.
CARDIOVASCULAR RESEARCH (2011)
DARC and D6: silent partners in chemokine regulation?
Chris A. H. Hansell et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Armanda Casrouge et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Barbara Molon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4
Nobuko Tano et al.
PLOS ONE (2011)
The Effect of CXCL12 Processing on CD34+ Cell Migration in Myeloproliferative Neoplasms
Sool Yeon Cho et al.
CANCER RESEARCH (2010)
Intrapersonal and Populational Heterogeneity of the Chemokine RANTES
Paul E. Oran et al.
CLINICAL CHEMISTRY (2010)
The evolution of mammalian chemokine genes
Hisayuki Nomiyama et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Posttranslational Modification of the NH2-terminal Region of CXCL5 by Proteases or Peptidylarginine Deiminases (PAD) Differently Affects Its Biological Activity
Anneleen Mortier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Role of Protein Tyrosine Nitration in Neurodegenerative Diseases and Atherosclerosis
Jung Rok Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Chemokines and chemokine receptors: an overview
Raffaella Bonecchi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation
Paul Proost et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Regulation of chemokine activity by posttranslational modification
Anneleen Mortier et al.
PHARMACOLOGY & THERAPEUTICS (2008)
LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity
Angus M. Tester et al.
PLOS ONE (2007)
Expression and targeting of CX(3)CL1 (Fractalkine) in renal tubular epithelial cells
Anne M. Durkan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mechanisms of disease: regulation of RANTES (CCL5) in renal disease
Alan M. Krensky et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration
David Vergote et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis
Tamara Loos et al.
LABORATORY INVESTIGATION (2006)
The biological relevance of chemokine-proteoglycan interactions
A. E. I. Proudfoot
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway
JH Ruth et al.
ARTHRITIS AND RHEUMATISM (2006)
CXC chemokines in angiogenesis
RM Strieter et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy
JK Damås et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development
A Rhode et al.
JOURNAL OF IMMUNOLOGY (2005)
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5
JK Kim et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1α in the circulation
DA Davis et al.
BLOOD (2005)
Proteolytic activation of alternative CCR1 ligands in inflammation
RD Berahovich et al.
JOURNAL OF IMMUNOLOGY (2005)
Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells
A Rot et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
The disintegrin-like metalloproteinase ADAM 10 is involved in coinstitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion
C Hundhausen et al.
BLOOD (2003)
CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system
S Kastenbauer et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Increased intrathecal release of soluble fractalkine in HIV-infected patients
B Sporer et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
The CX3C chemokine fractalkine in allergic asthma and rhinitis
AC Rimaniol et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis
P Proost et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma
E Schutyser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages
J Münch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
P Proost et al.
BLOOD (2001)
Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active [9-74] processed variant
J Vakili et al.
JOURNAL OF IMMUNOLOGY (2001)
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties
M Detheux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Posttranslationally processed forms of the human chemokine HCC-1
R Richter et al.
BIOCHEMISTRY (2000)
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
GA McQuibban et al.
SCIENCE (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
分享论文
